Taken together, these results provide evidence that IGFBP-1 contributes to the development of tamoxifen resistance in breast cancer cells and is a pro-survival signal for tamoxifen resistant breast cancer cells. The gene discussed is IGFBP1; the disease is breast carcinoma.